Justin Hoffman

978 total citations
36 papers, 736 citations indexed

About

Justin Hoffman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Justin Hoffman has authored 36 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Justin Hoffman's work include Advanced Breast Cancer Therapies (14 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Treatment and Pharmacology (6 papers). Justin Hoffman is often cited by papers focused on Advanced Breast Cancer Therapies (14 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Treatment and Pharmacology (6 papers). Justin Hoffman collaborates with scholars based in United States, United Kingdom and Japan. Justin Hoffman's co-authors include Carl J. Carrano, Yanke Yu, Diane Wang, Z. Shirin, Cho‐Ming Loi, Norikazu Masuda, Hiroji Iwata, Cynthia Huang Bartlett, Jungsil Ro and Ke Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Inorganic Chemistry.

In The Last Decade

Justin Hoffman

35 papers receiving 724 citations

Peers

Justin Hoffman

ONCOL

PRM

GENET

Christina Ng United States

Joon Cho South Korea

Brian J. Corden United States

Katharina Beyer Germany

John J. Huang United States

Fangyu Peng United States

Gwang Il An South Korea

Sang Ju Lee South Korea

Eli Dijkers Netherlands

Jennifer Shih United States

Christina Ng United States

Justin Hoffman

290 ×0.7

ONCOL

88 ×0.3

PRM

43 ×0.4

99 ×0.9

GENET

195 ×2.0

Citations per year, relative to Justin Hoffman Justin Hoffman (= 1×) peers Christina Ng

Countries citing papers authored by Justin Hoffman

Since Specialization

Citations

This map shows the geographic impact of Justin Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Hoffman more than expected).

Fields of papers citing papers by Justin Hoffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Hoffman. The network helps show where Justin Hoffman may publish in the future.

Co-authorship network of co-authors of Justin Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Hoffman. A scholar is included among the top collaborators of Justin Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Hoffman. Justin Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gupta, Shilpa, Miguel Á. Climent Durán, Howard Gurney, et al.. (2025). Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in older patients. ESMO Open. 10(4). 104506–104506. 2 indexed citations

Gupta, Sumati, et al.. (2024). P251 Avelumab first-Line Maintenance (1LM) in advanced Urothelial Carcinoma (aUC): Analysis of quality-adjusted time without symptoms or toxicity (Q-TWiST) in older patients (pts) from the JAVELIN Bladder 100 trial. European Urology Open Science. 69. 317–318. 1 indexed citations

Azad, Arun, et al.. (2023). 1829P Exposure-safety analyses of talazoparib in combination of enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in TALAPRO-2 trial. Annals of Oncology. 34. S990–S990. 1 indexed citations

Adkins, Douglas R., Assuntina G. Sacco, Jessica Ley, et al.. (2021). Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial. Oral Oncology. 115. 105192–105192. 27 indexed citations

Hoffman, Justin, et al.. (2021). Anti-NMDA receptor encephalitis and brain atrophy in children and adults: A quantitative study. Clinical Imaging. 78. 296–300. 8 indexed citations

Durairaj, Chandrasekar, Jayeta Chakrabarti, Cristiano Ferrario, et al.. (2021). The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors. Clinical Pharmacokinetics. 60(7). 921–930. 8 indexed citations

Mondello, Stefania, Travis A. Dittmer, Paul J. Schroeder, et al.. (2020). Characteristics and Impact of U.S. Military Blast-Related Mild Traumatic Brain Injury: A Systematic Review. Frontiers in Neurology. 11. 559318–559318. 83 indexed citations

Yu, Yanke, Justin Hoffman, Anna Plotka, et al.. (2020). Palbociclib (PD-0332991) pharmacokinetics in subjects with impaired renal function. Cancer Chemotherapy and Pharmacology. 86(6). 701–710. 10 indexed citations

Hoffman, Justin, Jayeta Chakrabarti, Anna Plotka, et al.. (2019). Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors. Anti-Cancer Drugs. 30(5). 523–532. 8 indexed citations

10.

Adkins, Douglas R., Jin‐Ching Lin, Assuntina G. Sacco, et al.. (2019). Palbociclib plus cetuximab versus placebo plus cetuximab in platinum-resistant, cetuximab-naive, HPV-unrelated head and neck cancer: A double-blind randomized phase II trial (PALATINUS).. Journal of Clinical Oncology. 37(15_suppl). 6013–6013. 14 indexed citations

11.

Durairaj, Chandrasekar, Ana Ruiz-Garcı́a, Eric Gauthier, et al.. (2018). Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer. Anti-Cancer Drugs. 29(3). 271–280. 33 indexed citations

12.

Loibl, Sibylle, Nicholas C. Turner, Jungsil Ro, et al.. (2017). Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results. The Oncologist. 22(9). 1028–1038. 99 indexed citations

13.

Iwata, Hiroji, Seock‐Ah Im, Norikazu Masuda, et al.. (2017). PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy—Safety and Efficacy in Asian Patients. Journal of Global Oncology. 3(4). 289–303. 96 indexed citations

14.

Keam, Bhumsuk, Makoto Tahara, Jin‐Ching Lin, et al.. (2016). An international, multicenter, randomized, double-blind, placebo-controlled, parallel-group phase 2 study of palbociclib (an oral CDK4/6 inhibitor) plus cetuximab in patients with recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN).. Journal of Clinical Oncology. 34(15_suppl). TPS6102–TPS6102. 1 indexed citations

15.

Gardinier, J.R., et al.. (2015). Supramolecular Assembly of Metal‐Organic Tubes Constructed from the Ditopic Heteroscorpionate Ligand (4‐NH2C6H4)CHpz2 (pz = Pyrazol‐1‐yl) and Silver(I). European Journal of Inorganic Chemistry. 2016(15-16). 2615–2625. 10 indexed citations

16.

Hoffman, Justin, et al.. (2014). A Phase 1 Open-Label Fixed-Sequence Two-Period Crossover Study of the Effect of Multiple Doses of Tamoxifen on Palbociclib (PD-0332991) Pharmacokinetics in Healthy Male Volunteers. Annals of Oncology. 25. i25–i25. 3 indexed citations

17.

Hoffman, Justin, et al.. (2013). Determination of Efavirenz in Human Dried Blood Spots by Reversed-phase High-performance Liquid Chromatography With UV Detection. Therapeutic Drug Monitoring. 35(2). 203–208. 21 indexed citations

18.

Hoffman, Justin, et al.. (2011). Probable Interaction Between Warfarin and Rifaximin in a Patient Treated for Small Intestine Bacterial Overgrowth. Annals of Pharmacotherapy. 45(5). 682–682. 13 indexed citations

19.

Carstairs, Shaun D., Andrew G. Urquhart, Justin Hoffman, Richard F. Clark, & F. Lee Cantrell. (2010). A Retrospective Review of Supratherapeutic Modafinil Exposures. Journal of Medical Toxicology. 6(3). 307–310. 23 indexed citations

20.

Hoffman, Justin, Ba L. Tran, & Carl J. Carrano. (2006). Oxidation-state and metal-ion dependent stereoisomerization in oxo molybdenum and tungsten complexes of a bulky alkoxy heteroscorpionate ligand. Dalton Transactions. 3822–3822. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact